Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Income from Non-Controlling Interests (2020 - 2022)

Ginkgo Bioworks Holdings' (DNA) quarterly Income from Non-Controlling Interests came in at $2.4 million in Q4 2022, up 155.08% on a YoY basis from $936954.3 in Q4 2021, and up 236.96% quarter-over-quarter from -$1.7 million in Q2 2022.

Analysis

Ginkgo Bioworks Holdings (DNA) Income from Non-Controlling Interests (2020 - 2022) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has reported Income from Non-Controlling Interests for 3 consecutive years, with $2.4 million the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Income from Non-Controlling Interests rose 155.08% year-over-year to $2.4 million; the trailing twelve-month figure through Sep 2023 stood at $2.4 million (up 129.25% YoY), and the FY2022 full-year result was -$1.4 million, up 78.12% from the prior year.
  • Income from Non-Controlling Interests advanced to $2.4 million in Q4 2022 per DNA's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $2.4 million in Q4 2022 and bottomed at -$4.3 million in Q4 2021.
  • Historically, Income from Non-Controlling Interests has averaged -$968888.9 across 3 years, with a median of -$753000.0 in 2020.
  • The sharpest annual moves came in 2021 and 2022: Income from Non-Controlling Interests plunged 838.03% in 2021, then soared 155.08% in 2022.
  • Over 3 years, Income from Non-Controlling Interests stood at -$753000.0 in 2020, then sank by 476.23% to -$4.3 million in 2021, then jumped by 155.08% to $2.4 million in 2022.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $2.4 million, -$1.7 million, and -$2.1 million for Q4 2022, Q2 2022, and Q1 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 2.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 722,000.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 19.44 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.39 Mn
Jun 30, 2022 -1.75 Mn
Mar 31, 2022 -2.09 Mn
Dec 31, 2021 -4.34 Mn
Sep 30, 2021 -524,000.00
Jun 30, 2021 -523,000.00
Mar 31, 2021 -1.21 Mn
Dec 31, 2020 -753,000.00
Sep 30, 2020 71,000.00